|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0005516,
umls-concept:C0008972,
umls-concept:C0035820,
umls-concept:C0138741,
umls-concept:C0194825,
umls-concept:C0220901,
umls-concept:C0376358,
umls-concept:C0439810,
umls-concept:C0441833,
umls-concept:C0443483,
umls-concept:C0456603,
umls-concept:C1366489,
umls-concept:C1417779,
umls-concept:C1550147
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2010-9-23
|
|
pubmed:abstractText |
To explore the significance of the pretreatment total prostate-specific antigen (PSA) to free testosterone (FT) ratio (PSA/FT) as a marker for assessing the pathologic Gleason sum (pGS) and levels of tumor extension (pT) in prostatectomy specimens.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1423-0399
|
|
pubmed:author |
pubmed-author:AntoniolliStefano ZecchiniSZ,
pubmed-author:CarusoBeatriceB,
pubmed-author:ComunaleLuigiL,
pubmed-author:GhimentonClaudioC,
pubmed-author:LacolaVincenzoV,
pubmed-author:MiglioriniFilippoF,
pubmed-author:MonacoCarmeloC,
pubmed-author:PetrozzielloAldoA,
pubmed-author:PorcaroAntonio BAB,
pubmed-author:RomanoMarioM,
pubmed-author:RubilottaEmanueleE,
pubmed-author:SavaTeodoroT
|
|
pubmed:copyrightInfo |
Copyright © 2010 S. Karger AG, Basel.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
85
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
152-8
|
|
pubmed:meshHeading |
pubmed-meshheading:20616526-Aged,
pubmed-meshheading:20616526-Chi-Square Distribution,
pubmed-meshheading:20616526-Cluster Analysis,
pubmed-meshheading:20616526-Humans,
pubmed-meshheading:20616526-Italy,
pubmed-meshheading:20616526-Male,
pubmed-meshheading:20616526-Middle Aged,
pubmed-meshheading:20616526-Neoplasm Invasiveness,
pubmed-meshheading:20616526-Neoplasm Staging,
pubmed-meshheading:20616526-Predictive Value of Tests,
pubmed-meshheading:20616526-Prostate-Specific Antigen,
pubmed-meshheading:20616526-Prostatectomy,
pubmed-meshheading:20616526-Prostatic Neoplasms,
pubmed-meshheading:20616526-Risk Assessment,
pubmed-meshheading:20616526-Risk Factors,
pubmed-meshheading:20616526-Testosterone,
pubmed-meshheading:20616526-Treatment Outcome
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Investigative clinical study on prostate cancer part II: on the role of the pretreatment total PSA to free testosterone ratio as a marker assessing prostate cancer prognostic groups after radical retropubic prostatectomy.
|
|
pubmed:affiliation |
Department of Urology, Azienda Ospedaliera Universitaria di Verona, Ospedale Civile Maggiore, Verona, Italy. drporcaro@yahoo.com
|
|
pubmed:publicationType |
Journal Article
|
